首页|安非他酮与齐拉西酮治疗女性精神分裂症后继发抑郁患者疗效及对患者心功能心脏代谢指标的影响

安非他酮与齐拉西酮治疗女性精神分裂症后继发抑郁患者疗效及对患者心功能心脏代谢指标的影响

扫码查看
目的 探讨安非他酮与齐拉西酮治疗女性精神分裂症后继发抑郁患者疗效及对患者心功能、心脏代谢指标的影响。方法 以2021年7月至2023年5月浙江省温州市第七人民医院收治的90例女性精神分裂症后继发抑郁患者为研究对象,按随机数字表法分为安非他酮组和齐拉西酮组,每组各45例。安非他酮组在抗精神病药物基础治疗上给予安非他酮治疗,齐拉西酮组在抗精神病药物基础治疗上给予齐拉西酮治疗。比较2组阳性与阴性症状量表(PANSS)、汉密尔顿抑郁量表(HAMD)及临床有效率;观察2组心功能指标[左室射血分数(LVEF)、左房内径(LAD)、左室收缩末内径(LVSD)及左室舒张末内径(LVEDD)]、心脏代谢指标[乳酸脱氢酶(LDH)、肌酸激酶同工酶(CK-MB)、天门冬氨酸氨基转氨酶(AST)]。结果 治疗2个月后,安非他酮组HAMD评分、PANSS评分均低于齐拉西酮组(P均<0。05),安非他酮组总有效率高于齐拉西酮组(P<0。05),安非他酮组LVEF、LAD、LVSD、LVEDD水平均低于齐拉西酮组(P均<0。05),安非他酮组LDH、CK-MB、AST水平均低于齐拉西酮组(P均<0。05)。结论 安非他酮治疗女性精神分裂症后继发抑郁患者疗效较齐拉西酮好,不仅可降低患者抑郁程度及临床症状,且对患者心功能和心脏代谢影响小。
Effects of bupropion and ziprasidone on female patients with secondary depression after schizophrenia and their influence on cardiac function and cardiac metabolic markers
Objective To explore the efficacy of bupropion and ziprasidone in the treatment of female patients with post-schizophrenia depression,as well as the effects on cardiac function and cardiac metabolic in-dexes.Methods A total of 90 female patients with post-schizophrenia depression at the Seventh People's Hospi-tal of Wenzhou City from July 2021 to May 2023 were selected as the research subjects.They were randomly di-vided into a bupropion group and a ziprasidone group,with 45 cases in each group.In addition to antipsychotic medication,the bupropion group was treated with bupropion,whereas the ziprasidone group was treated with ziprasidone.The positive and negative symptom scale(PANSS),Hamilton Depression Scale(HAMD),and clinical efficacy were compared between two groups.The cardiac function indicators[left ventricular ejection fraction(LVEF),left atrial diameter(LAD),left ventricular end systolic diameter(LVSD),and left ventricular end diastolic diameter(LVEDD)],as well as cardiac metabolic indicators[lactate dehydrogenase(LDH),creatine kinase isoen-zyme(CK-MB),and aspartate aminotransferase(AST)]were observed in two groups.Results After two months of treatment,the HAMD score and PANSS score of the bupropion group were lower than those of ziprasidone group(P<0.05),the total effective rate of the bupropion group was higher than that of ziprasidone group(P<0.05);in terms of cardiac function,the LVEF,LAD,LVSD and LVEDD levels of the bupropion group were lower than those of the ziprasidone group(P<0.05);and the LDH,CK-MB and AST levels of the bupropion group were lower than those of the ziprasidone group(P<0.05).Conclusion Bupropion is more effective than ziprasidone on female pa-tients with post-schizophrenia depression.It can not only reduce the degree of depression as well as clinical symp-toms,but also promote the improvement of cardiac function and metabolism.

BupropionZiprasidoneFemaleSchizophreniaCardiac functionCardiac metabolism

李传云、王锡武、单建敏

展开 >

温州市第七人民医院普通精神科,浙江温州 325006

安非他酮 齐拉西酮 女性 精神分裂症 心功能 心脏代谢

浙江省温州市科研项目

Y20210767

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(2)
  • 15